IPO YEAR:
|
Sector:
Health Care
|
Industry:
Biotechnology: In Vitro & In Vivo Diagnostic Substances
|
ADRTSO:
|
MarketCap:
16468761.00
|
Beta:
1.32359370130984
|
52 Week High:
5.4
|
52 Week Low:
2.25
|
52 Week Change:
0.021582733812949728
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
5120978
|
Dividend Rate:
0
|
Dividend Yield:
N/A
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
N/A
|
Float:
0
|
return on Equity:
-52.80%
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
-$4.38
|
ttmEPS:
-0.1878
|
Revenue:
$114.166M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
4.30%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
27.60%
|
Return on Assets:
-18.00%
|
Return on Capital:
|
Profit Margin:
-12.00%
|
Price to Sales:
0.14
|
Price To Book:
0.39
|
Short Ratio:
6.19
|
PE Ratio:
-15.587971618435152
|
Employees:
636
|
1Y Guesstimate
3.616:3.0:6
|
|
|
|
|
|
|
|
|
